Picture of Kazia Therapeutics logo

KZIA — Kazia Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Novogen patent covering cantrixil, trilexium accepted in Australia

Nov 12 (Reuters) - Novogen Ltd  NRT.AX : 
 * Patent covering cantrixil and trilexium accepted in Australia 
 * Announced that a patent application covering two of its key lead 
   superbenzopyran (sbp) drug candidates has been accepted in Australia 
 
 * Source text for Eikon  ID:nPn114wJ  
 
 * Further company coverage  NRT.AX   
 
 ((Bengaluru Newsroom; +1 646 223 8780))

Recent news on Kazia Therapeutics

See all news